176 related articles for article (PubMed ID: 36754752)
41. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
[TBL] [Abstract][Full Text] [Related]
42. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.
Lerut T; Nafteux P; Moons J; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Ectors N
Ann Surg; 2004 Dec; 240(6):962-72; discussion 972-4. PubMed ID: 15570202
[TBL] [Abstract][Full Text] [Related]
43. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.
Ye B; Zhong CX; Yang Y; Fang WT; Mao T; Ji CY; Li ZG
World J Gastroenterol; 2016 May; 22(19):4750-6. PubMed ID: 27217706
[TBL] [Abstract][Full Text] [Related]
44. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma.
Shim YM; Kim HK; Kim K
J Thorac Oncol; 2010 May; 5(5):707-12. PubMed ID: 20421764
[TBL] [Abstract][Full Text] [Related]
45. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection.
Fujita H; Kakegawa T; Yamana H; Shima I; Tanaka H; Ikeda S; Nogami S; Toh Y
World J Surg; 1994; 18(2):266-72. PubMed ID: 8042333
[TBL] [Abstract][Full Text] [Related]
46. [Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma].
Fang WT; Chen WH; Chen Y; Shen YZ; Jiang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):388-91. PubMed ID: 17043956
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of Postoperative Recurrence in Lymph Node-Negative Superficial Esophageal Carcinoma.
Ozawa Y; Kamei T; Nakano T; Taniyama Y; Miyagi S; Ohuchi N
World J Surg; 2016 Jul; 40(7):1663-71. PubMed ID: 26908240
[TBL] [Abstract][Full Text] [Related]
48. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma.
Doki Y; Ishikawa O; Takachi K; Miyashiro I; Sasaki Y; Ohigashi H; Murata K; Yamada T; Noura S; Eguchi H; Kabuto T; Imaoka S
World J Surg; 2005 Jun; 29(6):700-7. PubMed ID: 16078126
[TBL] [Abstract][Full Text] [Related]
49. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
[TBL] [Abstract][Full Text] [Related]
50. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma.
Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H
Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397
[TBL] [Abstract][Full Text] [Related]
51. [Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma].
Huang W; Li BS; Gong HY; Fan M; Sun HF; Zhou T; Liu XB
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):225-8. PubMed ID: 20450594
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma.
Qie P; Yin Q; Xun X; Song Y; Zhou S; Liu H; Feng J; Tian Z
J Cardiothorac Surg; 2021 Mar; 16(1):48. PubMed ID: 33757566
[TBL] [Abstract][Full Text] [Related]
53. Thoracoscopic radical esophagectomy combined with left inferior pulmonary ligament lymphadenectomy for esophageal carcinoma via the right thoracic approach: A single-center retrospective study of 30 cases.
Huang S; Yang T; Wang W; Huang G; Chen B; Chen P; Ke D; Huang W; Xie J
Medicine (Baltimore); 2021 Jun; 100(23):e26302. PubMed ID: 34115038
[TBL] [Abstract][Full Text] [Related]
54. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
55. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma.
Chen J; Liu S; Pan J; Zheng X; Zhu K; Zhu J; Xiao J; Ying M
Eur J Cardiothorac Surg; 2009 Sep; 36(3):480-6. PubMed ID: 19502077
[TBL] [Abstract][Full Text] [Related]
56. Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection.
Park SY; Lee J; Jeon YJ; Cho JH; Kim HK; Choi YS; Zo JI; Shim YM
Ann Surg Oncol; 2024 May; 31(5):3399-3408. PubMed ID: 38082171
[TBL] [Abstract][Full Text] [Related]
57. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
[TBL] [Abstract][Full Text] [Related]
58. Significance of Upper Mediastinal Lymph Node Dissection with Video-Assisted Thoracic Surgery in the Treatment of Middle Thoracic Esophageal Carcinoma.
Lv WQ; Wei WZ; Wu WB; Zeng GQ; Huang RX; Zhang LS
J Laparoendosc Adv Surg Tech A; 2017 Oct; 27(10):1061-1064. PubMed ID: 28574749
[TBL] [Abstract][Full Text] [Related]
59. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
Wang Y; Zhu L; Xia W; Wu L; Wang F
World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
[TBL] [Abstract][Full Text] [Related]
60. The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy.
Chen J; Cai W; Zheng X; Chen Y; Lin Y; Chen X; Zhu K; Chen C
Radiother Oncol; 2017 Jun; 123(3):382-386. PubMed ID: 28551110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
